Search results
As the leader in non-invasive neuroimaging, Kernel believes in data-driven development and scalable technology. Our brain-based biomarkers, action-focused solutions, and reliable data can empower and accelerate your goals. Transform the future of neuromedicine today by partnering with us.
- Vision & Team
As the leader in non-invasive neuroimaging, Kernel believes...
- News
In the last year we launched Kernel Flow2, shipped our first...
- FAQ
Kernel Resource Center. Learn how to use your Kernel system....
- Vision & Team
History. Johnson founded Kernel in 2016 with a $54 million investment and began researching neuroprosthetics, devices implanted into the brain that mimic, substitute, or assist brain functions. [1] [3] In May 2020, Kernel introduced two brain-activity monitoring devices, Flux and Flow.
Kernel is revolutionizing precision neuroscience. We are using our proprietary, first-in-class neurotechnology to build the world's most comprehensive portfolio of brain-based biomarkers. Our mission is to accelerate treatment discovery, improve patient outcomes, and transform neuromedicine.
Kernel's category-defining neuroimaging platform can be used to accelerate treatment development, improve patient outcomes, and reduce healthcare costs. Website. https://www.kernel.com....
Kernel Neurotech. @kernelco ‧. 3.16K subscribers ‧ 12 videos. 🧠 Revolutionizing precision neuroscience with the most comprehensive portfolio of brain-based biomarkers. kernel.com and 2 more...
25 Ogo 2021 · In 2016, Johnson founded his own neurotechnology company, Kernel. While his ultimate dream of cognitive evolution sounds pie in the sky, Kernel’s current goal is more contained: to explore and measure the brain by making the tools to do so more accessible and capable.